Back to search

United States· US:68788-8764_6621210b-edd5-46f6-aa72-f4befa35bccc

Quetiapine fumarate

A quetiapine product containing quetiapine fumarate, registered in United States by : Preferred Pharmaceuticals Inc.. The same ATC class is registered in 18 of our 19 countries.

ATC N05AH04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedQuetiapine fumarateATCN05AH04REGISTER NO.US:68788-8764_6621210…PACKS LISTED10CHECKEDSeptember 27, 2026

Where it is registered

Quetiapine is registered in 18 of 19 countries.

Countries holding a registration under ATC N05AH04 (quetiapine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose

Quetiapine · ATC N05AH04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of quetiapine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.19 in United States to $3.93 in Switzerland — a ×20 gap.

  • United States: $0.19 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Quetiapine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.93
  • ES Spain$2.46
  • IT Italy$2.42
  • FR France$0.90
  • US United States$0.19 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
QUETIAPINE FUMARATE
Manufacturer
: Preferred Pharmaceuticals Inc.
Country
United States (US)
ATC code
N05AH04
ATC class
Quetiapine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 10

  • ndc11
    6878887641
    100 TABLET in 1 BOTTLE (68788-8764-1)
  • ndc11
    6878887643
    30 TABLET in 1 BOTTLE (68788-8764-3)
  • ndc11
    6878887646
    60 TABLET in 1 BOTTLE (68788-8764-6)
  • ndc11
    6878887648
    120 TABLET in 1 BOTTLE (68788-8764-8)
  • ndc11
    6878887649
    90 TABLET in 1 BOTTLE (68788-8764-9)
  • ndc11
    68788-8764-1
  • ndc11
    68788-8764-3
  • ndc11
    68788-8764-6
  • ndc11
    68788-8764-8
  • ndc11
    68788-8764-9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

559 interactions on record for quetiapine.

Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Quetiapine · interactions on record

559 records

  • 61 severe
  • 281 moderate
  • 7 minor
  • 132 info

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe

78 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8790999-fbe6-4788-bca4-a6df0ed62329
GET /v1/drugs/f8790999-fbe6-4788-bca4-a6df0ed62329?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "25",
  "substance": "QUETIAPINE FUMARATE",
  "productndc": "68788-8764",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA201109",
  "marketing_category": "ANDA"
}

See everything about quetiapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.